Medical News

RSS

View News A-Z »

Natus Medical anticipates revenue of $247M to $250M for full year 2011

Natus Medical Incorporated today announced its financial guidance for the first quarter and full year 2011.

20 Dec 2010

MEDNAX acquires Neonatology Associates in Kingsport

MEDNAX, Inc., today announced the acquisition of a neonatal physician group based in Kingsport, TN.

20 Dec 2010

Food sack to help supplement Cincinnati students' nutrition through the holiday break

To help fight childhood hunger, every pledge to Cincinnati Public Radio today will feed four Cincinnati children through Childhood Food Solutions (CFS) Food Sacks and Green B.E.A.N. Delivery.

20 Dec 2010

Hyperpriming in early stages of Alzheimer's disease explained

The capacity to remember that a zebra has stripes, or that a giraffe is a four-legged mammal, is known as semantic memory. It allows us to assign meaning to words and to recall general knowledge and concepts that we have learned. The deterioration of these capacities is a defining feature of semantic dementia and can also occur in Alzheimer's disease.

20 Dec 2010

AHF calls on Sen. Nelson to address Florida's AIDS drug crisis

On Monday, December 20 at 6:00 PM, AIDS Healthcare Foundation (AHF) will host a town hall and public forum at the African Heritage Cultural Arts Center calling on U.S. Senator Bill Nelson to immediately address Florida's AIDS drug crisis which has left nearly 2,400 patients without access to lifesaving AIDS medications. Town hall attendees will include AIDS advocates, patients, healthcare professionals, community leaders and concerned citizens.

20 Dec 2010

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has demonstrated the ability to capture immunosuppressive exosomes derived from individuals with lymphoma and colorectal cancer.

20 Dec 2010

Positive top-line results from VEGF Trap-Eye Phase 3 studies in macular edema due to CRVO

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with macular edema due to central retinal vein occlusion (CRVO).

20 Dec 2010

U.K. decision to close operations at Forensic Science Service could contribute to Orchid Cellmark's growth

Orchid Cellmark Inc., a leading international provider of identity DNA testing services, said today the decision by the United Kingdom government to wind-down operations at the Forensic Science Service (FSS) could contribute to Orchid Cellmark's ongoing growth.

20 Dec 2010

Exciting progress made in MS research during 2010

Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first therapy specifically approved to treat a symptom of MS (Ampyra).

20 Dec 2010

Response Biomedical strengthens patent protection for RAMP technology

Response Biomedical Corporation today announced that the United States Patent and Trademark Office issued an official Notice of Allowance on one of the Company's patent applications regarding the RAMP® technology. The patent entitled "Comparative Multiple Analyte Immunoassay" is expected to issue in the first quarter of 2011.

20 Dec 2010

SanguiBioTech, SanderStrothmann establish sastOmed

SanguiBioTech GmbH, Witten, Germany, and SanderStrothmann GmbH, Georgsmarienhuette, Germany, have established a joint venture company under the name of sastOmed GmbH. The respective agreements and articles were now signed, and recorded by a notary.

20 Dec 2010

Dell receives CEO Cancer Gold Standard accreditation

Dell has received CEO Cancer Gold Standard™ accreditation, recognizing the company's commitment to reducing the cancer risk of its employees and their families by encouraging healthy lifestyles and promoting early detection through screenings, and by providing quality care, including access to cancer clinical trials, when a cancer diagnosis becomes a reality.

20 Dec 2010

VIVUS seeks marketing approval of QNEXA in the EU

VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.

20 Dec 2010

Chelsea completes successful NORTHERA pre-NDA assessment with FDA

Chelsea Therapeutics International, Ltd. announced it has completed a pre-NDA assessment with the U.S. Food and Drug Administration (FDA) and intends to accelerate its new drug application (NDA) for NORTHERA™(droxidopa) for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH), a chronic and potentially debilitating drop in blood pressure upon standing commonly associated Parkinson's disease, multiple system atrophy and pure autonomic failure.

20 Dec 2010

Stereotaxis closes $40 million credit facility

Stereotaxis, Inc. announced today that the Company has closed on its previously announced $40 million credit facility, which includes a $30 million revolving facility that matures on March 31, 2012 and a $10 million term loan that matures on December 31, 2013. The new facility was led by Silicon Valley Bank, and replaces the Company's previous facility that was scheduled to mature in March 2011.

20 Dec 2010

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

With value-based purchasing (VBP) now law under health reform, hospitals participating in the nation's largest hospital VBP demonstration are providing lessons learned that can help others save lives and better craft rules to govern the new program.

20 Dec 2010

Progress report on 'Strategy for Europe on nutrition, overweight and obesity'

December has been a busy month for the European Commission, and Despina Spanou, Principal Adviser at the Directorate General for Health and Consumers, talks to EUFIC, about Europe's Nutrition Strategy mid-term progress report, the evaluation of the EU Platform for Action on Diet, Physical Activity and Health, the OECD/EC report "Health at a Glance: Europe 2010", and the Belgian Presidency/EC Conference on Monitoring and Evaluation of EU and Member States' strategies on nutrition, overweight and obesity-related health issues.

20 Dec 2010

Health Care at Home: Trends and issues

Leaders in the nation's Health Care at Home movement outlined trends and issues during a webinar for physicians across the country today. The webinar, "Why Health Care is Going Home," offered industry insights and detailed the reasons why home care will play a major role in the future of health care in America.

20 Dec 2010

NAFC forms council to establish independent quality standards for incontinence products

The National Association For Continence (NAFC) is heading a newly formed council with the objective of establishing national, independent quality standards for disposable adult absorbent products provided by states to Medicaid waiver recipients cared for in their private homes rather than as residents of a state-funded nursing home.

20 Dec 2010

Comprehensive guidance for care providers on Dementia Care Mapping process

Dementia is a critical health concern, but are the current care services able to offer appropriate support? Only a few days ago, the review by the Royal College of Psychiatrists found many dementia patients were not getting the support on nutrition and mental health that they should. The need for improved care is higher than ever.

20 Dec 2010